Private Advisor Group LLC Decreases Stock Holdings in UiPath Inc. (NYSE:PATH)

Private Advisor Group LLC reduced its holdings in shares of UiPath Inc. (NYSE:PATH) by 16.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,368 shares of the healthcare company’s stock after selling 4,301 shares during the quarter. Private Advisor Group LLC’s holdings in UiPath were worth $274,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of the business. Global Financial Private Client LLC boosted its stake in shares of UiPath by 9.3% in the first quarter. Global Financial Private Client LLC now owns 6,471 shares of the healthcare company’s stock valued at $144,000 after purchasing an additional 551 shares during the period. Advisors Asset Management Inc. boosted its stake in shares of UiPath by 35.0% in the first quarter. Advisors Asset Management Inc. now owns 3,037 shares of the healthcare company’s stock valued at $69,000 after purchasing an additional 787 shares during the period. Empowered Funds LLC boosted its stake in shares of UiPath by 10.5% in the first quarter. Empowered Funds LLC now owns 10,856 shares of the healthcare company’s stock valued at $246,000 after purchasing an additional 1,033 shares during the period. ORG Partners LLC boosted its stake in shares of UiPath by 875.6% in the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after purchasing an additional 1,112 shares during the period. Finally, Daiwa Securities Group Inc. boosted its stake in UiPath by 5.4% during the 1st quarter. Daiwa Securities Group Inc. now owns 25,400 shares of the healthcare company’s stock valued at $576,000 after acquiring an additional 1,300 shares during the last quarter. 62.50% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have commented on the stock. Barclays increased their price objective on shares of UiPath from $14.00 to $15.00 and gave the company an “equal weight” rating in a research note on Friday, September 6th. Bank of America increased their price objective on shares of UiPath from $16.00 to $18.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Royal Bank of Canada reiterated a “sector perform” rating and set a $16.00 price objective on shares of UiPath in a research note on Friday, September 6th. DA Davidson increased their price objective on shares of UiPath from $13.00 to $15.00 and gave the company a “neutral” rating in a research note on Friday, September 6th. Finally, Needham & Company LLC reiterated a “hold” rating on shares of UiPath in a research note on Wednesday, October 23rd. Sixteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $17.47.

UiPath Stock Up 1.8 %

PATH stock opened at $13.39 on Friday. UiPath Inc. has a fifty-two week low of $10.37 and a fifty-two week high of $27.87. The firm’s 50-day simple moving average is $12.53 and its 200 day simple moving average is $13.69. The stock has a market cap of $7.36 billion, a PE ratio of -65.80 and a beta of 0.87.

UiPath (NYSE:PATH) last released its quarterly earnings data on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The business had revenue of $316.00 million for the quarter, compared to analysts’ expectations of $303.69 million. During the same quarter last year, the company earned ($0.09) EPS. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. Equities analysts forecast that UiPath Inc. will post -0.23 EPS for the current fiscal year.

Insider Activity at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $12.07, for a total value of $575,388.97. Following the completion of the transaction, the chief financial officer now owns 849,917 shares in the company, valued at $10,258,498.19. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. 22.37% of the stock is currently owned by insiders.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.